
GlycanAge
GlycanAge provides biological age tests using glycan biomarkers to support preventative healthcare.
Filter & sort
Recently funded companies in the UK tech ecosystem.

GlycanAge provides biological age tests using glycan biomarkers to support preventative healthcare.
IMU Biosciences builds a proprietary artificial intelligence platform for deep immune profiling and precision medicine.
Iceni Diagnostics develops rapid point-of-care diagnostic tests and carbohydrate-based medical products.
Invizius develops treatments to prevent life threatening inflammation during dialysis.

Kheiron develops machine learning software to assist radiologists with breast cancer detection.
Kuano combines quantum mechanics and AI to design targeted enzyme inhibitors.